Exploring the utilization of supplements, natural products, and medications among Jordanian COVID-19 patients
Main Article Content
Keywords
Vitamins, Dietary Supplements, natural products, medication, Jordan, COVID-19
Abstract
Background: The COVID-19 pandemic has significantly impacted global health, leading individuals to explore several treatments, including pharmaceutical medications, dietary supplements, and natural products, in order to manage their symptoms. Understanding these treatment patterns is vital for public health planning and policy development. Methods: A cross-sectional survey was conducted from February to May 2021, to investigate the use of supplements, natural products, and medications among Jordanian COVID-19 patients, assessing the prevalence, types, and perceived effectiveness of these interventions. Data were collected using a structured questionnaire. Participants were recruited through social media. Descriptive statistics and chi-square tests were employed for data analysis through SPSS. Results: The study included 1,178 Jordanian individuals who had contracted COVID-19. Of the participants, 54.8% were female, and 44.9% were aged 18-25. The most commonly reported symptoms were loss of smell (63.8%), headache (63.3%), and sore muscles (59.0%). Regarding treatment, 82.4% used at least one vitamin, with vitamin C (75.8%) and zinc (59.9%) being the most used. Natural substances such as honey (36.3%) and ginger (34.6%) were also widely used among the participants. Antipyretics, especially Paracetamol (60.5%), were the most frequently used drugs. Many participants perceived these treatments as effective, with vitamin C and honey being rated as effective by 62.9% and 67.8% of users, respectively. Conclusion: The study highlights a high prevalence of supplement and natural product use among Jordanian COVID-19 patients. These findings provide valuable insights into patient behaviors and can inform future healthcare strategies and policy formulations in similar contexts. Understanding these patterns is essential for developing effective public health guidelines and interventions during pandemics.
References
2020;730. doi:10.1016/j.scitotenv.2020.138996
2. Jirjees F, Barakat M, Shubbar Q, Othman B, Alzubaidi H, Al-Obaidi H. Perceptions of COVID-19 symptoms, prevention, and
treatment strategies among people in seven Arab countries: A cross-sectional study. J Infect Public Health. 2022;15(10):1108-1117. doi:10.1016/j.jiph.2022.08.019
3. Thiab SH, Nassar RI, Thiab S, Basheti IA. Medications and natural products used in Jordan for prevention or treatment of
COVID-19 infection during the second wave of the pandemic: A cross-sectional online survey. Saudi Pharmaceutical Journal.
2022;30(6). doi:10.1016/j.jsps.2022.03.006
4. Nassar RI, Thiab S, Basheti IA. The battle against COVID-19 in Jordan: A cross-sectional study assessing the experience of
Jordanians who have been infected with COVID-19. Pharm Pract (Granada). 2023;21(1). doi:10.18549/PharmPract.2023.1.2791
5. Chavda VP, Patel AB, Vihol D, et al. Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update. Clinical Complementary Medicine and Pharmacology. 2022;2(1):100021. doi:10.1016/j.ccmp.2022.100021
6. Nassar RI, Thiab S, Alkoudsi KT, Basheti IA. COVID-19 infected patients ’ experiences in Syria, and the role of the pharmacists
during their infection. Pharm Pract (Granada). 2022;20(1).
7. Yáñez JA, Chung SA, Román BR, et al. Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses
for COVID-19. Environmental and Health Management of Novel Coronavirus Disease (COVID-19). 2021:379-416. doi:10.1016/B978-0-323-85780-2.00001-9
8. Amuzie CI, Kalu KU, Izuka M, et al. Prevalence, pattern and predictors of self-medication for COVID-19 among residents in
Umuahia, Abia State, Southeast Nigeria: policy and public health implications. J Pharm Policy Pract. 2022;15(1):34. doi:10.1186/s40545-022-00429-9
9. Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto- person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-523. doi:10.1016/S0140-6736(20)30154-9
10. Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q. Epidemiological analysis of COVID‐19 and practical experience from China. J Med
Virol. 2020:755-769.
11. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019- nCoV) infections among travellers
from Wuhan, China, 20–28 January 2020. Eurosurveillance. 2020;25(5):1-6. doi:10.2807/1560-7917.ES.2020.25.5.2000062
12. Zaki N, Mohamed EA. The estimations of the COVID-19 incubation period: A scoping reviews of the literature. J Infect Public Health. 2021;14(5):638-646. doi:10.1016/j.jiph.2021.01.019
13. Icek A. The Theory of Planned Behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
14. Nassar RI, Basheti IA, Saini B. Exploring Validated Self-Reported Instruments to Assess Adherence to Medications Used: A
Review Comparing Existing Instruments. Patient Prefer Adherence. 2022;16:503-513. doi:10.2147/PPA.S352161
15. Puttock EJ, Marquez J, Young DR, et al. Association of masking policies with mask adherence and distancing during the SARSCOV- 2 pandemic. Am J Infect Control. Published online 2022. doi:10.1016/j.ajic.2022.04.010
16. The World Health Organization. Coronavirus disease (COVID-19). https://www.who.int/health-topics/coronavirus#tab=tab_3
17. Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARSCoV-
2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15. doi:10.1371/journal.pone.0234765
18. Samrah SM, Al-mistarehi A hameed W, Ibnian AM, et al. COVID-19 outbreak in Jordan: Epidemiological features,
clinical characteristics, and laboratory findings. Annals of Medicine and Surgery. 2020;57(June):103-108. doi:10.1016/j.amsu.2020.07.020
19. Aman F, Masood S. How Nutrition can help to fight against COVID-19 Pandemic. Pak J Med Sci. 2020;36:121-123.
20. Jovic TH, Ali SR, Ibrahim N, et al. Could Vitamins Help in the Fight Against COVID-19? Nutrients. 2020;12(9):1-30. doi:10.3390/nu12092550
21. Sharma L. Dietary management to build adaptive immunity against COVID-19. Journal of PeerScientist. 2020;2(2):1-6.
22. Abobaker A, Alzwi A, Alraied AHA. Overview of the possible role of vitamin C in management of COVID-19. Pharmacological
Reports. 2020;72:1517-1528.
23. Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self‐medication drugs to prevent or treat COVID‐19: Experience from a Middle Eastern country. Int J Clin Pract. 2021;75(11). doi:10.1111/ijcp.14860
24. Nassar RI, Thiab S, Alkoudsi KT, Basheti IA. COVID-19 infected patients ’ experiences in Syria, and the role of the pharmacists during their infection. Pharm Pract (Granada). 2022;20(1).
25. Thiab S, Barakat M, Al-Qudah R, Abutaima R, Jamal R, Riby P. The Perception of Jordanian Population Towards Concomitant
Administration of Food, Beverages and Herbs with Drugs and Their Possible Interactions: A Cross-Sectional Study. Int J Clin
Pract. 2020;75(3). doi:10.1111/ijcp.13780
26. Abdel-Qader DH, Albassam A, Ismael NS, et al. Herbal medicine use in the Jordanian population: A nationally representative
cross-sectional survey. J Pharm Pharmacogn Res. 2020;8(6):525-536.
27. Nguyen PH, Tran V De, Pham DT, Dao TNP, Dewey RS. Use of and attitudes towards herbal medicine during the COVID-19
pandemic: A cross-sectional study in Vietnam. Eur J Integr Med. 2021;44:101328. doi:10.1016/j.eujim.2021.101328
28. Abdullah Alotiby A, Naif Al-Harbi L. Prevalence of using herbs and natural products as a protective measure during the COVID-19 pandemic among the Saudi population: an online cross-sectional survey. Saudi Pharmaceutical Journal. 2021;29(5):410-417. doi:10.1016/j.jsps.2021.04.001
29. Ahmed I, Hasan M, Akter R, et al. Behavioral preventive measures and the use of medicines and herbal products among the
public in response to Covid-19 in Bangladesh: A cross-sectional study. PLoS One. 2020;15(12 December):1-12. doi:10.1371/
journal.pone.0243706
30. Khadka D, Dhamala MK, Li F, et al. The use of medicinal plants to prevent COVID-19 in Nepal. J Ethnobiol Ethnomed.
2021;17(1):1-17. doi:10.1186/s13002-021-00449-w
31. Parham S, Kharazi AZ, Bakhsheshi-Rad HR, et al. Antioxidant, antimicrobial and antiviral properties of herbal materials.
Antioxidants. 2020;9(12):1-36. doi:10.3390/antiox9121309
32. The World Health Organization. Coronavirus disease (COVID-19) Q&As.
33. The World Health Organization. Clinical management of severe acute respiratory infection ( SARI) when COVID-19 disease is
suspected: interim guidance, 13 March 2020. Published online 2020.
34. DGoH S. National Guidelines on Clinical Management of Coronavirus Disease 2019 (Covid-19).
35. Echeverría-esnal D, Martin-ontiyuelo C, Navarrete- ME, et al. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021;19(2):147-164. doi:10.1080/14787210.2020.1813024
36. Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID19: More Than Just an Antimicrobial? Clin Drug Investig. 2020;40(8):683-686. doi:10.1007/s40261-020-00933-3
37. Risch HA. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. Am J Epidemiol. 2020;189(11):1218-1226. doi:10.1093/aje/kwaa093
38. Magagnoli J, Pereira F, Cummings TH, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19. Med. Published online 2020. doi:10.1016/j.medj.2020.06.001
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.